Selendy Gay PLLC
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Litigation specialist Selendy Gay PLLC is built for high-stakes disputes. The group is led by New York-based practice heads and founding partners Jennifer Selendy, whose expertise encompasses a broad range of commercial and post-M&A disputes, often involving earnouts, contractual rights and fiduciary duty claims; Philippe Selendy, a formidable trial lawyer in multibillion-dollar, bet-the-company matters; and Faith Gay, who brings deep capability in investigations, jury trials, and cross-border disputes. Also among the firm’s leadership bench are Maria Ginzburg, who is deeply immersed in commercial and financial structuring disputes, particularly shareholder- and creditor-side litigation, and Andrew Dunlap, who focuses on financial services and complex commercial litigation, including securities, healthcare, antitrust, mass tort, and contract matters. ‘Smart’ and ’very pragmatic’, David Flugman is a key litigator within the team who handles commercial and bankruptcy disputes. Two other emerging partners within the firm are Meredith Nelson and Julie Singer, who both are experienced in representing clients in complex commercial disputes, corporate governance, and shareholder actions in both federal and state courts.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Selendy Gay is a reasonable priced firm that can litigate with the best attorneys in New York. They are also very practical in the advice they provide.'
- 'They are extremely intelligent, diligent, and practical.'
Key clients
- Fortis Advisors LLC
- Albertsons Companies
Work highlights
Represented Fortis Advisors LLC in its capacity as the representative for former shareholders of Auris Health, Inc. in a merger earnout dispute with its acquiror, Johnson & Johnson. After four years of litigation, the Delaware Court of Chancery ruled that Johnson & Johnson owed the former shareholders more than $1.1bn in damages.


